Bedside to Bench: Integrating Quantitative Clinical Pharmacology and Reverse Translation to Optimize Drug Development

E-ISSN： 1532-6535|103|2|196-198

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.103, Iss.2, 2018-02, pp. : 196-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transporters in Drug Development and Clinical Pharmacology

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 94, Iss. 1, 2013-07 ,pp. : 3-9

John Wiley & Sons Inc

Access to resources Recommend Favorite

How Well Are We Applying Quantitative Methods to Reverse Translation to Inform Early Clinical Development?

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 103, Iss. 2, 2018-02 ,pp. : 174-176

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quantitative clinical pharmacology for size and age scaling in pediatric drug development: A systematic review

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 91-2700, Iss. 11, 2015-11 ,pp. : 1207-1217

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quantitative clinical pharmacology for size and age scaling in pediatric drug development: A systematic review

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 11, 2015-11 ,pp. : 1207-1217

John Wiley & Sons Inc

Access to resources Recommend Favorite

From bench to bedside: a review of the clinical trial development plan of drotrecogin alfa (activated)

By Short Mary A. Schlichting Douglas Qualy Rebecca L.

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2525-2540

Informa Healthcare

Access to resources Recommend Favorite